May 9, 2018 / 8:17 PM / 2 months ago

BRIEF-CytomX Therapeutics Q1 Revenue $14.2 Mln Vs I/B/E/S View $16.4 Mln

May 9 (Reuters) - CytomX Therapeutics Inc:

* CYTOMX THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 REVENUE $14.2 MILLION VERSUS I/B/E/S VIEW $16.4 MILLION

* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.40

* Q1 EARNINGS PER SHARE VIEW $-0.44, REVENUE VIEW $16.4 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below